25 May 2012

Smallcap Weekly

Growth Company Investor's weekly recommendation round-up

12/06/2009 James Crux

Driver – growth potential undisputed

Increasingly diverse in terms of geographic and sector presence, as well as services offered, dispute resolution specialist Driver motored in with record half-year sales and profits.

Steered by energetic CEO Steve Driver, the group grew sales 49 per cent to £11.25 million in the half to March, reflecting strong growth in the Middle East and currency benefits arising from sterling weakness, as well as a strong six months from early 2008 acquisition CMC, which Driver sees as a cracker of a deal, bringing cross-selling potential aplenty. Pre-tax profits powered north by 40 per cent to £1.3 million and the dividend was increased by five per cent to 1p.

Though feeling the impact of reduced commercial construction activity in the UK and Dubai, Driver is more than shrugging off the recession due to its geographic diversity and increasingly broad service offering.

Turning its hand to everything from dispute resolution to project consultancy and expert witness provision, Driver is able to earn money across numerous engineering and construction market sub-sectors, oil and gas, power and civil engineering among them.

Developing its expert witness and litigation support services in the growth markets of London, the UAE and Oman, while making progress in the Far East and Americas, Driver has plenty of growth to go for in highly fragmented markets.

For the year, WH Ireland number cruncher John Cummins has pencilled in growth in profits and earnings to £2.6 million (2008: £2.1 million) and 8p (2008: 6.3p) respectively, placing the shares, currently priced at 73.5p, on a forward multiple of less than ten times. That rating is ungenerous given growth rates – investors yet to climb on board should take the opportunity to do so now.

Resilient May Gurney underrated

Recommended here at 280p a year ago, May Gurney (MAYG) may be trading at a much lower 177p, yet the company has reminded the market about its resilient credentials with a tenth consecutive year of record sales and profits.

Full-year results to March from the AIM-quoted infrastructure support services star were bang in line with forecasts, showing sales improved from £437 million to more than £470 million and eight per cent growth at the pre-tax line to £20.2 million. Drawing confidence from better than expected year-end net cash of £18.6 million, the board upped the annual dividend payout by 11 per cent to 5.125p.

May Gurney’s robustness stems from the fact that more than 95 per cent of sales are derived from long-term contracts, through which it delivers maintenance and enhancement services to defensive public and regulated sectors. Crucially, the company is all about essential ‘front line’ maintenance – it is not exposed to capital project spend, the area at most risk from likely public sector budget cuts.

With a burgeoning order book worth more than £1.25 billion, May Gurney also boasts excellent visibility of sales and continues to see a healthy pipeline of bid possibilities and business wins. Recent contract wins and deal extensions include a canal and river network maintenance deal with British Waterways, worth £80 million over four years, and a new household waste recycling deal with Essex County Council, as well as extensions totalling £150 million for long-standing customers Network Rail and Norfolk County Council.

This year, City analysts see profits pushing higher again to £21.8 million, producing earnings of 21.9p and a 5.4p dividend. On those estimates, the shares are selling for eight times earnings, offer a three per cent yield and remain terrific value. Hold/buy.

Red24 in the black

Security risk management concern Red24 (REDT) turned previous losses into a £500,000 profit before tax in the year to March, after slashing costs and growing its top line.

The Berkshire-based company, which is steered by chief executive and former army parachutist Maldwyn Worsley-Tonks, lifted revenues 20 per cent to £3.3 million and, after taking out ‘unnecessary’ costs, turned losses of £343,000 into pre-tax profits of £537,000. This left the AIM-traded counter with much improved cash balances of £626,000 at the year-end, despite repaying a third of its loan stock in the fourth quarter.

A new service, ‘Travel Tracker’, which enables companies to locate employees travelling abroad, has been ‘well received’, while the group’s training arm enjoyed underlying growth of around five per cent. Of its two main distribution partners, HSBC and insurer AIG, now AIU Holdings, the latter famously suffered a tumultuous year, yet Red24 still managed to grow revenue ‘significantly’, particularly in North America.

Now cash positive and with payment of its loan stock extended to the end of September 2010, the news has been well received by the market, with the shares, tipped here at 3.25p in November, having marched higher to 4.62p, valuing the company at £2.05 million. They should have further to go, so if you bought on our advice, sit tight.

AMS ‘weighting’ on second half

Elsewhere, wound treatment developer Advanced Medical Solutions (AMS), backed strongly here at 32p in March and now 25p, says it is confident of further growth this year. However, the company concedes that growth will be weighted towards the second half.

At the Cheshire-based concern's annual meeting, chairman Dr Geoffrey Vernon assured that recent organic growth is set to continue this year, with regulatory approval for the AIM-traded group's LiquiBand skin 'superglue' in the US expected in the second half.

'The difficult global economic conditions are affecting our partners,' he admitted, 'and we expect to see a significant effect on half-year phasing, with a higher than normal second-half loading this year.'

'However, given the exciting, imminent product launches and market entry opportunities, the board remains confident in the outlook for the 2009 full year,' he concluded.

The company recently revealed that clinical studies had shown its surgical adhesive product InteguSeal 'significantly' reduced infection after cardiac surgery. Further data is expected during the second half and, says AMS, should boost demand for the product in 2010.

Shares in AMS, debt-free and having grown profits almost 55 per cent to £2.9 million in 2008, may be below our tip price, but the company's cost-effective offering has the potential to move the shares much higher over time and outperform many peers. Hold for recovery and more.

Recommendation update        
  Price rec. Price now Change Rec. now
  p p    
Apr-08        
Rheochem 13.00 6.42 -50.62% Hold/Buy
Gold Oil 9.32 3.67 -60.62% Hold
Real Good Food 10.25 4.00 -60.98% Hold/Buy
         
May-08        
GoIndustry 10.00 2.19 -78.10% Hold
nCipher 166.00 300.00 80.72% Sold
Clean Diesel Technology 640.00 117.50 -81.64% Hold/Buy
Filtrona 161.75 120.75 -25.35% Hold
         
Jun-08        
Immunodiagnostic Systems 186.50 252.00 35.12% Buy
Redhall 291.00 181.75 -37.54% Hold/Buy
Latchways 895.00 545.00 -39.11% Hold/Buy
Scott Wilson 219.75 65.00 -70.42% Sell
B.P. Marsh 123.00 91.50 -25.61% Hold
May Gurney 280.00 173.00 -38.21% Hold/Buy
         
Jul-08        
Cyril Sweett 66.00 25.00 -62.12% Hold/Buy
Oxford Catalysts 164.50 58.00 -64.74% Hold/Buy
RWS 380.00 300.00 -21.05% Strong Buy
PAQ International 2.25 0.90 -60.00% Hold/Buy
         
Aug-08        
Patsystems 17.00 23.74 39.65% Hold/Buy
Matchtech 267.50 140.00 -47.66% Buy
Tikit 213.50 130.00 -39.11% Hold
Stadium 54.00 40.80 -24.44% Buy
Dignity 742.50 590.50 -20.47% Hold/Buy
H&T Group 191.00 220.00 15.18% Firm Hold
         
Sep-08        
RCG Holdings 75.75 74.50 -1.65% Strong Buy
James Fisher 590.00 435.25 -26.23% Strong Buy
Ant 36.50 32.00 -12.33% Buy
Essentially 10.75 3.27 -69.58% Buy
Proton Power Systems 8.25 5.68 -31.15% Buy
Nationwide Accident Repair Services 125.50 84.00 -33.07% Buy
Vindon Healthcare 20.00 20.65 3.25% Buy
         
Oct-08        
Deal Group Media 0.48 0.40 -16.67% Hold/Buy
Nautical Petroleum 38.00 58.30 53.42% Hold/Buy
Ebiquity 29.50 30.35 2.88% Speculative Buy
e-Therapeutics 38.50 33.00 -14.29% Buy
Strategic Thought 51.50 32.00 -37.86% Buy
GSH Group 240.00 180.00 -25.00% Hold/Buy
         
Nov-08        
Red24 3.25 5.00 53.85% Hold
Cohort 161.00 174.50 8.39% Hold/Buy
Circle Oil 18.50 32.50 75.68% Speculative Buy
Boomerang Plus 158.00 74.50 -52.85% Buy
Vane Minerals 3.38 5.88 73.96% Speculative Buy
Diamondcorp 43.50 30.00 -31.03% Hold
Norcros 7.13 9.00 26.23% Speculative Buy
Superglass 30.50 29.80 -2.30% Speculative Buy
Futura Medical 27.50 23.75 -13.64% Firm Hold
         
Dec-08        
Deltex Medical 12.25 12.52 2.20% Hold
ACM Shipping 150.00 190.00 26.67% Buy
OPG Power Ventures 22.00 41.75 89.77% Hold/Buy
DQ Entertainment 80.00 58.00 -27.50% Strong Buy
         
Jan-09        
William Sinclair 50.50 76.50 51.49% Buy
Summit Corporation 27.50 5.19 -81.13% Buy
Vantis 67.00 86.50 29.10% Hold/Buy
Iofina 45.00 83.33 85.18% Hold/Buy
ReNeuron 13.00 4.85 -62.69% Hold/Add
Clean Air Power 21.50 26.40 22.79% Hold
Alliance Pharma 4.50 12.25 172.22% Hold/Buy
Advanced Power Components 10.50 15.00 42.86% Speculative Buy
         
Feb-09        
Akers Biosciences 13.75 19.50 41.82% Buy
Oakley Capital Investments 62.00 72.25 16.53% Hold
Hargreaves Services 545.00 521.90 -4.24% Strong Buy
Telecom Plus 325.50 276.26 -15.13% Buy
Goldplat 12.25 11.00 -10.20% Speculative Buy
Allied Gold 20.00 23.62 18.10% Speculative Buy
 
Mar-09        
WSP 200.25 247.27 23.48% Buy
InterQuest 35.50 46.50 30.99% Hold/Buy
Ultimate Finance 5.50 6.49 18.00% Hold/Buy
Satcom 14.50 12.25 -15.52% Speculative Buy
Advanced Medical Solutions 32.00 25.05 -21.72% Hold
K3 Business Technology 62.50 76.84 22.94% Buy
Victoria Oil & Gas 4.00 4.09 2.25% Hold
Glencar Mining 4.38 4.00 -8.68% Hold/Buy
         
Apr-09        
Zotefoams 59.50 53.50 -10.08% Speculative Buy
Chesnara 138.50 145.00 4.69% Hold/Buy
Symphony Environmental Technologies 3.00 4.65 55.00% Add
Plexus 25.00 35.80 43.20% Speculative Buy
Eaga 149.00 127.75 -14.26% Buy
TEG 52.00 48.65 -6.44% Hold/Buy
Churchill China 220.00 235.00 6.82% Buy
Delcam 201.50 255.00 26.55% Buy
Gas Turbine Efficiency 25.50 33.50 31.37% Buy
SciSys 37.50 42.00 12.00% Speculative Buy
Velosi 66.50 81.00 21.80% Buy
LiDCO 10.75 11.98 11.44% Speculative Buy
China Shoto 193.50 200.00 3.36% Buy
Kalahari Minerals 112.00 133.25 18.97% Hold
Sareum Holdings 0.50 0.33 -34.00% Speculative Buy
         
May-09        
Northbridge Industrial Services 155.00 120.00 -22.58% Buy
StatPro 65.50 73.00 11.45% Speculative Buy
Faroe Petroleum 81.00 74.90 -7.53% Speculative Buy
Iomart 36.50 36.45 -0.14% Buy
Melorio 127.50 156.00 22.35% Buy
Verona Pharma 5.75 6.25 8.70% Hold
Merchant Securities 6.75 8.00 18.52% Speculative Buy
Platmin 56.50 48.90 -13.45% Speculative Buy
Fountains 64.00 67.94 6.16% Buy
         
Jun-09        
Chloride 152.75 150.00 -1.80% Buy
Driver 73.50 75.00 2.04% Buy

Tags: Buy/Hold, Dividend, Growth Stocks, Undervalued

Companies: Advanced Medical Solutions , May Gurney Integrated Services , red24 , Driver

Achieve impressive returns

Gain instant access to some of the best-performing and fastest growing companies in the small cap arena

Click here

Stocks & Shares ISA

Online tools to make investments easy and low admin fee from The Share Centre. Find out more.

Achieve impressive returns on the go

Gain instant access to some of the best-performing and fastest growing companies in the small cap arena. Sign up NOW!

Institutional Investors in AIM 2011 - New Report

This unique study analyses the shareholdings of companies listed on AIM, extracting trends including rankings of the value and number of their investments.
Please click here to order your copy of the report or call 0207 250 7056.

Coverage of AIM, techMARK and PLUS Markets

Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.

If you're interested in business tax updates visit our specialist tax guide website.

Growth Company Features, Research and Analysis

In-depth coverage of selected AIM companies within the small-cap and fast growing company sector including AIM and PLUS Markets shares and listed stocks. Company research and analysis from GCI analysts updated daily.

Popular Features

Latest Features

Fund manager focus 21/05/2012

Paul Marriage, who has been investing in small-caps for over a decade, explains to Ellie Duncan how his unique stockpicking strategy has produced consistent returns

Directors’ Dealings 21/05/2012

With a flurry of buys and sells taking place across the junior market, it pays to think carefully about directors’ intentions, says Ben Jaglom

Pick of AIM 21/05/2012

The tricky IPO market over recent years has led to careful vetting by institutional investors. Miles Nolan investigates two impressive newcomers

More Features

Sectors